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Summary
 
We have characterized the calcium response of a peptide–major histocompatibility complex
(MHC)-specific CD4
 
1
 
 T lymphocyte line at the single cell level using a variety of ligands,
alone and in combination. We are able to distinguish four general patterns of intracellular cal-
cium elevation, with only the most robust correlating with T cell proliferation. Whereas all
three antagonist peptides tested reduce the calcium response to an agonist ligand, two give very
different calcium release patterns and the third gives none at all, arguing that (
 
a
 
) antagonism
does not require calcium release and (
 
b
 
) it involves interactions that are more T cell receptor
proximal. We have also measured the time between the first T cell–antigen-presenting cell
contact and the onset of the calcium signal. The duration of this delay correlates with the
strength of the stimulus, with stronger stimuli giving a more rapid response. The dose depen-
dence of this delay suggests that the rate-limiting step in triggering the calcium response is not
the clustering of peptide–MHC complexes on the cell surface but more likely involves the ac-
cumulation of some intracellular molecule or complex with a half-life of a few minutes.
 
T
 
he binding of T cell receptor to a specific MHC–pep-
tide complex is the critical step in T cell activation as it
initiates the intracellular signaling cascade in the T cell (re-
viewed in reference 1). The first known step in this cascade
is the tyrosine phosphorylation of CD3 chains (2, 3). Among
other downstream events, these phosphorylations lead to an
increase in the level of intracellular calcium (reviewed in
reference 4). Initially, calcium is released from intracellular
stores, followed by an influx of exogenous calcium through
calcium-specific channels in the cell membrane (5, 6). The
direct coupling of CD3 phosphorylation to calcium mobi-
lization has been demonstrated by reconstitution of this sig-
naling pathway in COS-1 cells (7).
One major effect of the elevated calcium levels is the ac-
tivation of calcineurin. This leads to the translocation of the
cytoplasmic component of the T cell–specific transcription
factor NF-AT
 
1
 
 to the nucleus and the initiation of tran-
scription (8). The shape and mobility of T cells are also reg-
ulated by calcium (9, 10). Changes in intracellular calcium
levels can be observed directly at the single cell level using
ratiometric fluorescent dyes (9–14). While there is general
agreement that the calcium signal is a specific consequence
of T cell activation, the form and dose response of the sig-
nal remain controversial.
Apart from the calcium signal, other signaling pathways
are activated following the engagement of the TCR. These
include the pathway leading to the activation of the ERK
kinases of the MAP kinase family via ras and raf (reviewed
in reference 1). In addition, other T cell surface receptors
such as B7 and cytokine receptors have been demonstrated
to contribute to T cell activation (15, 16).
In addition to the TCR, the T cell coreceptor CD4 also
binds to MHC class II, although its binding is not antigen
specific. The cytoplasmic tail of CD4 can associate with the
tyrosine kinase lck and recruit lck to the TCR complex (17).
But even when the lck kinase domain is inactive (18) or in
the absence of the CD4–lck association (19, 20) CD4 can
contribute to the activation of T cells.
Altering antigenic peptides without decreasing their abil-
ity to bind to the MHC can have dramatic effects on T cell
responses (reviewed in references 21–24). Some altered
peptides elicit only a subset of the responses induced by the
original peptide and thus have been labeled partial agonists
(25, 26). Some inhibit an otherwise productive response to
the original peptide and can thus be considered antagonists
 
1
 
Abbreviations used in this paper:
 
 CHO, Chinese hamster ovary; MCC,
moth cytochrome C; NF-AT, nuclear factor of activated T cell.
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(27). Such antagonist peptides alone trigger some biochem-
ical events in T cells, resulting in partial phosphorylation of
the CD3-
 
z
 
 chain (28–32). It has been found that the bio-
logical effect of a series of altered peptides correlates, with
very few exceptions, with the half-life of the corresponding
MHC–peptide–TCR complexes in vitro (28–30). Such a cor-
relation has also been suggested based on work with agonists
(33) and on theoretical grounds (34, 35).
In a previous study (36), we correlated different biologi-
cal responses elicited by a set of altered peptides. This has
been done in the presence or absence of blocking antibod-
ies against CD4. We find that the different biological re-
sponses can be organized into a hierarchy of signaling, from
ones elicited by most altered peptides to ones elicited only
by the wild-type peptide and variants of it with minimal al-
terations. In this study, we characterize the form, frequency,
and time course of the calcium response to different pep-
tides at the single cell level. We show that the calcium sig-
nal reflects the postulated hierarchy of signaling and is pre-
dictive of subsequent T cell proliferation. In addition, we
measure a delay between T cell–APC contact and the onset
of the calcium signal, which is dependent on the strength
of the activating stimulus. We suggest a model to explain
this delay in the onset of the calcium signal in which the
rate-limiting step in triggering the calcium response in-
volves the accumulation of an intracellular signaling mole-
cule with a half-life of a few minutes.
 
Materials and Methods
 
Peptides and Antibodies.
 
Peptides were synthesized with stan-
dard FMOC chemistry and purified by reverse phase HPLC.
Anti-CD4 antibody GK1.5 was purchased from Becton-Dickin-
son (Mountain View, CA).
 
Cell Line.
 
The moth cytochrome 
 
c 
 
(MCC)-specific 5C.C7 T
cells were derived from the 5C.C7 TCR transgenic mouse (37,
38). Spleen cells were primed with 10 
 
m
 
M MCC peptide and ex-
panded for 8 d in IL-2 containing medium. The T cells (1 
 
3
 
 10
 
6
 
cells/ml) were restimulated with irradiated (3,000 rads) B10.BR
spleen cells and 10 
 
m
 
M MCC peptide. After 10 d of culture and
expansion in the presence of IL-2, CD4
 
1
 
 cells were sorted by
flow cytometry and restimulated in 10-d intervals.
 
Calcium Imaging.
 
For calcium imaging, 5C.C7 T cells were
loaded for 30 min at room temperature with 2 
 
m
 
M Fura-2 in
10% FCS in PBS with 1 mM CaCl
 
2
 
 and 0.5 mM MgCl
 
2
 
. Chinese
hamster ovary (CHO) cells transfected with I-E
 
k
 
 were grown in
8-well coverslips (Nunc, Naperville, IL) and peptide loaded with
25 
 
m
 
M peptide for 4–16 h. Peptide loading efficiency throughout
this time range was almost constant. After washing unbound pep-
tide away with 5% FCS in PBS with 1 mM CaCl
 
2
 
 and 0.5 mM
MgCl
 
2
 
, Fura-2–loaded T cells were added onto a patch of conflu-
ent CHO cells on the microscope stage to start the experiment.
Intracellular calcium in T cells was determined using C-Imaging-
1280 System hardware and the Simca Quantitative Fluorescence
Analysis software package; both from Compix, Inc., Imaging Sys-
tems (Mars, PA). The imaging system was coupled to a Nikon
Diaphot 300 inverted microscope, which was equipped with the
epifluorescence attachment and a 75W Xenon arc lamp. Alter-
nate excitation of Fura-2–loaded T cells at 340 and 380 nm was
achieved using a Ludl high speed dual filter wheel (Ludl Elec-
tronic Products, Hawthorne, NY) controlled by the Simca soft-
ware. Images were collected with a CCD camera (Dage-MTI
CCD72) in combination with a SuperGenII intensifier, (Dage-
MTI, Michigan City, IN) to amplify fluorescence. Analysis of in-
tracellular calcium and the generation of figures was achieved with
the Simca software package. Per run, 30 to 40 cells were picked
at random and analyzed. Data of different runs were pooled. For
the figures, data of different experiments in which the topic of the
figure was studied in direct comparison of the conditions under
question was pooled. Only the 102S titration series (part of Figs.
2 and 3) shows a single representative experiment. The fluores-
cence of the Fura-2–loaded T cell is only visible when the T cell
is right on top of the CHO layer. Because the T cells are added to
the chamber from the top, their appearance in the fluorescence
image is taken as the time of first contact.
 
Kinetic Model.
 
One signaling component, A, will be con-
verted into another, B, with the rate constant k
 
1
 
, triggered by the
MHC–peptide–TCR contact. Both the concentration of peptide
and the type of peptide, as described by the half-life of its MHC–
peptide–TCR complex (28–30), influence k
 
1
 
. Because partial ag-
onist and antagonist peptides give a qualitatively different signal
the effect on k
 
1
 
 of changing the peptide type shall be much more
drastic than changing the peptide concentration. Using a first or-
der kinetics, and assuming that the concentration of B before the
MHC–peptide–TCR contact is 0, the concentration of A is A
 
0
 
, B
would form over time with B(t) 
 
5
 
 A
 
0
 
 
 
3
 
 (1 
 
2
 
 e
 
(
 
2
 
k1t)
 
). We now
suggest that a minimal amount of B has to form to propagate the
signal, the trigger concentration B
 
tr
 
. The time t
 
tr
 
 that is needed to
accumulate B
 
tr
 
 is given by: t
 
tr
 
 
 
5
 
 
 
2
 
k
 
1
 
2
 
1
 
 
 
3
 
 ln(1 
 
2
 
 B
 
tr
 
/A
 
0
 
). From
this formula it can be seen that the smaller k
 
1
 
 is, the longer it will
take to reach the trigger concentration. However, one problem
with this simple description is that even very weak signals would
trigger activation, given enough time. As we do not observe this
we suggest that, either directly or indirectly, B reverts back to A
with the rate constant k
 
2
 
1
 
 that for reasons of simplicity is assumed
to be independent of the MHC–peptide–TCR contact. The rate
of the formation of B then becomes B(t) 
 
5
 
 A
 
0
 
 
 
3 
 
(1 
 
1
 
 k
 
2
 
1
 
 / k
 
1
 
) 
 
3
 
(1 
 
2
 
 e
 
(k
 
1
 
1
 
k
 
2
 
1
 
)
 
t
 
). Using this model, the maximum amount of B that
is formed depends on the ratio of k
 
2
 
1
 
 to k
 
1
 
. The smaller k
 
1
 
 is rel-
ative to k
 
2
 
1
 
, the smaller this maximum level will be. Using weak
activation conditions, as very low concentrations of peptide or
antagonist peptides by themselves, the trigger level is never
reached.
 
Results
 
Different Stimuli Elicit Distinct Calcium Signals.
 
A number
of TCRs have been characterized that recognize the MCC
peptide (88–103) restricted by I-E
 
k
 
. Different variants of
the peptide have been studied in several respects: (
 
a
 
) pep-
tide binding to I-E
 
k
 
 (39), (
 
b
 
) kinetic rate constants for the
binding of the peptide–MHC to the 2B4 and 5C.C7 TCR
(30, 33, 40), (
 
c
 
) ability to stimulate IL-3 production, prolif-
eration, and acid release in a 5C.C7 line (36, 39). Taking
advantage of this extensive data set, we chose one of the
best studied of these models, 5C.C7, to characterize the
changes in the concentration of intracellular calcium after
T cell activation in response to different stimuli. The par-
ticular 5C.C7 line we chose to study is derived from the
CD4
 
1
 
 cells of the spleen of 5C.C7 TCR transgenic mice
(37; Fazekas de St. Groth, B., and M.M. Davis, unpublished 
1817
 
Wülfing et al.
 
results). It is maintained by periodic restimulation with an-
tigen (36). As an APC, we have used CHO cells transfected
with I-Ek, which can effectively stimulate a variety of T cells
(41, 42).
The calcium response to well-characterized peptides in
the MCC family was studied (Fig. 1). For all of them the
anchor residues to the MHC are unchanged, and thus
binding to I-E
 
k
 
 is very similar (39). Two of the three major
TCR contact residues, positions 99 and 102 (39, 43), were
changed more or less drastically in different peptides.
The changes in the level of intracellular calcium during
T cell stimulation were recorded from single cells for 16–
18 min, using the calcium-sensitive fluorescent dye, Fura-2
(45). In a single cell assay differences in the response within
a population of responders can be resolved, allowing more
extensive analysis. This proved to be crucial in particular
for the characterization of different types of calcium signals.
The experiments were done at 25
 
8
 
C. Relative differences
in type, frequency, and timing of the calcium signal are the
same as at 37
 
8
 
C, but the movement of the cells after activa-
tion is considerably less (Wülfing, C., and M.M. Davis,
data not shown). This reduction in cell movement at 25
 
8
 
C
allows a more precise determination of the form of the cal-
cium signal. In our assays, we first recorded the time be-
tween APC–T cell contact and the onset of the calcium
signal. Second, the form of the calcium signal after the on-
set, as judged by the emission of the dye Fura-2 when sub-
sequently excited at 340 nm and 380 nm, as well as the ra-
tio of these emissions, was classified. Analyzing not only the
ratio, but also the single emission traces, allows us to distin-
guish between specific elevation of intracellular calcium
and ratio changes caused by the movement of the cells be-
fore activation.
Under different activation conditions, we find four types
of calcium signals. Each starts with a rapid rise in intracellu-
lar calcium. However, the calcium levels after this initial
rise vary. Using the MCC peptide, more than 95% of the
cells respond with full signal, as shown in Fig. 2 and de-
scribed in Table 1. With the altered peptides, we find three
qualitatively different variants of the full signal, a reduced,
partial, and transient signal (Fig. 2; Table 1). These describe
the increasingly weaker calcium responses that we see and
have predictive value.
 
Calcium Responses Change with Different Peptides
 
Fig. 3 sum-
marizes the T cell calcium signaling triggered by the pep-
tides used in this report. Using the MCC peptide the re-
sponse is full, as discussed above. For the partial agonist
peptide 102S, the frequency of signaling is the same as for
the MCC peptide, but for almost a third of the cells the
signal is not complete. For the antagonist 102G peptide,
both the frequency of signaling and the signal type are sig-
nificantly different. The antagonist peptide 99R gives no
signaling at all above background. The background level is
defined using no peptide or the neutral MCC93E99T102A
variant, which shows no biological response in acid release
and proliferation assays and no measurable affinity to the
2B4 TCR. In both of these cases, we see no full signals and
reduced or partial signals in less than 10% of the T cells
(Fig. 3).
To determine the effect of low concentrations of stimu-
lating peptide in a defined manner, the MCC and 102S
peptides were each serially diluted into the neutral peptide
93E99T102A, such that the total peptide concentration
during loading of the APCs is kept constant at 25 
 
m
 
M. As
shown in Fig. 3, diluting the MCC peptide 1:1,000, result-
ing in a 25 nM MCC concentration, has no effect on the
frequency or the type of the calcium signal. At a 1:10,000
dilution of the MCC (2.5 nM), more than 85% of the cells
still respond with a full signal (see Fig. 5 
 
A
 
). When 102S is
diluted into MCC93E99T102A in a dilution series ranging
from 25 
 
m
 
M to 25 nM, the signaling frequency throughout
the series is still almost 100% (Fig. 3). However, at a 25
nM (1:1,000 dilution), 70% of the cells respond with a re-
duced signal, as opposed to 30% at 25 
 
m
 
M.
The altered or absent calcium response for the peptides
102S, 102G, and 99R correlates well with the other bio-
logical effects of these peptides (Table 2). The loss of ex-
tended elevation in the calcium signal in the 102S dilution
series correlates with a profound reduction in the ability of
102S to induce proliferation (36). The strongly reduced or
absent calcium signal of the 102G and 99R antagonist pep-
tides correlates with their lack of ability to induce any pro-
liferation. As shown by Rabinowitz et al. (36) the acidifica-
tion response is an early T cell activation event with both
Figure 1. Peptides used. At the top of the figure the sequence of the
MCC peptide is shown. The main TCR contact residues are indicated
with an upward arrow, the main MHC contact residues with a downward
arrow. Numbers indicate amino acid residue numbers of the MCC pro-
tein. Underneath, the altered peptides are listed. Only the residues that de-
viate from the wild-type sequence are shown. The mutation at the position
93 has no effect on either MHC binding or T cell stimulation (39, 44).
 
Table 1.
 
Types of Calcium Signals
 
Type Onset Form of the signal over time
Full Singular Sustained high
Reduced Singular Declining or fluctuating above resting 
calcium level
Partial Multiple Fluctuating down to resting calcium level
Transient Singular Rapid return to resting calcium level
Four general types of calcium signals are observed according to the
number of rapid rises from baseline, 
 
onset
 
, and the form of the calcium
signal after the initial rise, 
 
form of the signal over time
 
. Corresponding sin-
gle cell calcium traces are shown in Fig. 2. 
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Figure 2. Types of calcium
signals. For each signaling type,
as indicated by the name at the
top left and defined in Table 1,
two examples are given that each
consist of a pair of panels. In the
top panel (single trace image),
the ratio of the emission intensi-
ties at 340 nm over 380 nm is
shown. This is proportional to
the intracellular calcium level. In
the bottom panel (double trace
image), separate emission inten-
sities at 340 nm and 380 nm are
shown. The emission intensity at
380 nm is stronger than the
emission intensity at 340 nm at
the beginning of the recording
and can thus be identified. Occa-
sional strong fluctuations at the
beginning of the images in both
wavelengths and the ratio (e.g.,
left partial panel) are explained
by out of focus fluorescence
while the T cell settles into the
plane of focus of the objective. It
can be identified in the single
wavelength images by very low
intensities followed by a parallel
increase in both wavelength.
The individual wavelength traces
help in the distinction between
full and reduced signals. In a re-
duced signal the 380 nm trace
does not fall close to (right panel)
or does not stay close to (left
panel) baseline after activation. 
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MCC and 102S giving identical dose-response curves. This
is reflected in a high calcium signal responder frequency for
both. On the other hand, the strongly reduced or absent
calcium signal for 102G and 99R correlates with the lack of
an acidification response. Because acidification is measured
in a bulk assay, the small degree of activation measured in a
single cell calcium assay, e.g., for the peptide 102G, might
not be detectable above background in the acid release as-
say. Thus, only a full calcium signal correlates with a prolif-
eration response. In contrast, acid release correlates with a
high frequency response, irrespective of signal type.
 
The Time Between T Cell–APC Contact and Onset of the
Calcium Signal Is Determined by the Strength of the Activating
Stimulus.
 
The design of our calcium assay allows us to de-
termine the precise time between first APC–T cell contact
and the rise in intracellular calcium. We refer to this as the
onset delay. This onset delay is composed of two compo-
nents. Even under the strongest activation conditions, there
is a minimal time delay of 
 
z
 
1 min for the activation of the
first T cells. Using weaker stimuli, we find that the onset
delay increases as the stimulus gets weaker (Fig. 4). This de-
lay is seen both in the time it takes to activate the first cell,
as well as in the average onset time of the T cells in a given
experiment.
For the MCC peptide, the onset delay is the shortest
with an average of about 3 min and stays unchanged even
at 25 nM MCC (a dilution of 1:1,000 into the neutral pep-
tide 93E99T102A) (Fig. 4). 25 
 
m
 
M 102S or 102S diluted
only 1:10 into the neutral peptide (2.5 
 
m
 
M) shows an onset
delay that is similar to MCC. However, at lower concen-
trations there is a significant increase in the onset delay with
a shift from about 3 min to 6 min for 25 nM 102S (1:1,000
dilution into the neutral peptide) (Fig. 4). Furthermore, the
antagonist peptide, 102G, gives an onset delay of 10 min,
in combination with a strongly reduced responder fre-
quency. In general, a full calcium signal shows a rapid on-
set, a slightly reduced calcium signal shows a small onset
Figure 3. Frequency and type of the calcium response to MCC and al-
tered peptides. The percentage of each signal type for different peptides at
different dilutions. Signal types are given in the legend. Peptide names are
given in the first row at the bottom of each column. 99T102A stands for
the peptide 93E99T102A. When MCC or 102S has been diluted into
the neutral peptide 93E99T102A, the concentration of MCC or 102S is
given in the bottom row. The total peptide concentration is always 25 mM.
 
Table 2.
 
Comparison of Calcium Data with Other Biological Assays
 
Peptide
Acid release Calcium signal (percentage/quality/onset) Proliferation
10 
 
m
 
M 10 nM 25 
 
m
 
M 25 nM 10 
 
m
 
M 10 nM
MCC
 
11
 
100%/full/immediate 100%/full/immediate
 
11
 
MCC 1 anti-CD4 1 ND ND 100%/reduced/immediate 11
102S 11 100%/reduced/immediate 100%/reduced/delayed 16
102S 1 anti-CD4 1 ND ND 100%/reduced/delayed 22
102G 22 15%/reduced/delayed ND 22
99R 22 0% ND 22
Neutral peptide 22 0% ND 2 ND
MCC in 102G ND 80%/reduced/delayed 2
MCC in 99R 6 80%/reduced/delayed 2
The proliferation and acidification data are taken from Rabinowitz et al. (36) and are compared with the calcium data of this study. Peptides are
given in the first column. In the bottom part of the table where two peptides are given, the first has been diluted into the second 1:1,000. 1 anti
CD4 denotes the presence of 100 ng/ml of the anti-CD4 antibody GK1.5. Peptides have been used at the concentration that is indicated at the top
of each column. The small peptide concentration in the second calcium data column has been achieved by a 1:1,000 dilution of the peptides into the
neutral peptide, resulting in 25 nM concentration. For the acidification and proliferation assays, a plus signifies a strong response, plus/minus signifies
weak response, and minus signifies no detectable response. For the calcium assays three readouts are compiled: percentage signifies the percentage of
responding cells: 100% signifies virtually all cells respond, 0% signifies no responders. Quality indicates the types of calcium signal: ,10% reduced or
nil signals are seen or .10% of reduced or nil signals, as indicated by full or reduced. Onset gives the onset time of the calcium signal: .50% of the
cells activate within the first 4 min or not, as indicated by immediate versus delayed.1820 Kinetics and Extent of T Cell Activation
delay, and a strongly reduced calcium signal displays a large
onset delay. Thus, this delay in T cell activation seems to
be an integral part of the response to different ligands.
Blocking CD4 and Antagonism. We also studied the ef-
fect of blocking CD4 coreceptor engagement on the 102S
and MCC calcium response. In the presence of 100 ng/ml
of the anti-CD4 antibody GK1.5, the calcium signal in-
duced by 25 nM MCC or 102S is reduced with respect to
the frequency and type of signal (Fig. 5 A). The onset is not
significantly delayed (Fig. 5 B). This suggests that CD4
plays a role predominantly after the onset of the calcium
signal. The inhibition of the calcium signal by CD4 corre-
lates with the data of Rabinowitz et al. (36), who have
shown that GK1.5 blocks proliferation in response to
MCC and 102S.
The peptides 99R and 102G have been shown to act as
antagonists in cytokine secretion and proliferation assays
(Reay et al., in preparation; 36). Furthermore, the partial
agonist 102S can be changed into an antagonist in the pres-
ence of 100 ng/ml of the anti-CD4 antibody (36). To as-
sess the effect of antagonists on the calcium response, the
MCC peptide was serially diluted into the three different
antagonist conditions. For a 1:10,000 dilution of MCC into
102S/GK1.5, resulting in 2.5 nM MCC concentration,
10% of the cells do not respond at all, and 30% respond
with a reduced calcium signal (Fig. 6 A). This is essentially
the same signal seen with the 102S peptide and GK1.5
alone without any MCC (see Fig. 5). A 1:10,000 dilution
of the MCC into 99R and 102G leads to a reduction in the
frequency of responding cells to less than 40%, and almost
all calcium signals are partial (Fig. 6 B). Thus, the normal
MCC calcium response can be efficiently antagonized un-
der limiting activation conditions. In all three cases, the an-
tagonist effect depends strongly on the concentration of the
agonist, as MCC diluted to 1:1,000 shows only a small an-
tagonistic effect, as judged by the slight reduction in type
and frequency of the calcium signal (Fig. 6 A). Interest-
ingly, however, all three antagonist conditions delay the
onset of the calcium signal, ranging from slightly (about 1
min larger) to more than twice as long (Fig. 6 B).
Discussion
Intracellular Calcium Elevation and T Cell Responsiveness.
We show here that the form of the intracellular calcium
traces can vary widely depending on the activation condi-
tions. Under fully activating conditions, the calcium trace
shows a rapid rise followed by a smooth plateau. Under
suboptimal activation conditions, the intracellular calcium
concentration fluctuates considerably more after the initial
rise (Fig. 2). Other investigators have described single cell
calcium traces for peptide-dependent T cell activation at high
concentrations of agonist peptide or with cross-linking anti-
CD3 antibody. They found either oscillations (9, 11, 14, 46)
or smooth calcium traces (47), or a combination of both
forms (12). While these different results may be due to dif-
Figure 4. Onset of the calcium response to MCC and altered peptides.
Cumulative representation of percent of cells activated (irrespective of the
type of signal) during a specific onset time interval. Numbers on the time
axis indicate end time point of the interval, i.e., cells activating within 2
min after initial APC contact are shown at time point 2. Peptide name is
given in the legend. When MCC or 102S have been diluted into the
neutral peptide 93E99T102A, the concentration of MCC or 102S is also
given in the legend. Total peptide concentration is always 25 mM.
Figure 5. Effect of anti-CD4 antibody GK1.5 on the type and onset of
the calcium signals. (A) Percentages of each signal type (as explained in
Fig. 3). MCC or 102S were diluted 1:1,000 into the neutral peptide
MCC93E99T102A, resulting in 25 nM concentration. The type of pep-
tide and the absence or presence of the antibody GK1.5 are indicated un-
der the columns. The antibody concentration is 100 ng/ml. (B) Cumula-
tive representation of % cells activated (irrespective of the type of signal)
during a specific onset time interval. Time axis as in Fig. 4 B. Conditions
are as in A and are indicated in the header.1821 Wülfing et al.
ferent ligands used, an alternative explanation relates to the
degree of transformation of the T cells. When we compare
calcium traces from 5C.C7 naive cells, T cells primed once,
multiply primed T cells, i.e., the line used in this publica-
tion, and an restimulation-independent 5C.C7 T cell line,
we find that the incidence of oscillations increases with the
degree of transformation of the T cells (Wülfing, C., and
M.M. Davis, in preparation). Consistent with this, the
studies that show the most oscillatory T cell calcium traces
(14, 46) both used hybridomas.
In the system used here, we find that the elevation of in-
tracellular calcium varies from the full response to various
reduced or oscillatory patterns and that this correlates with
other bioassays as summarized in Table 2. A positive result
in the acidification assay is always accompanied by some
calcium signaling, whereas a proliferative response corre-
lates with a full calcium signal in most of the cells. Even a
small disturbance of the full signal, such as a delayed onset
or a response from less than 100% of the T cells, correlates
with an inability of the stimulus to induce proliferation of
the whole population. This suggests that the need for para-
crine help may require the proliferation of the large major-
ity of the individual cells in a population. Furthermore,
other intracellular signaling pathways that are necessary for
full T cell activation may be activated independent of the
calcium signal to some extent. Nevertheless, the importance
of a sustained calcium signal has been shown by Timmer-
man et al. (48), who have demonstrated that only a sus-
tained calcium elevation signal is able to keep NF-ATc in
the nucleus. Similarly, Negulescu et al. (46) have shown
that a sustained elevation of the intracellular calcium con-
centration is necessary for the activation of an IL-2 pro-
moter reporter construct. From the data of Karttunen and
Shastri (49) and Valitutti et al. (50), it also appears that a full
calcium stimulus must be maintained for at least 30–60 min
to induce an irreversible commitment to T cell activation,
particularly at lower peptide concentrations. Given the im-
portance of the sustained phase of the calcium signal, a
small reduction might contribute significantly to a severe
reduction in proliferation.
During activation, the T cell receives a wide variety of
signals through a large number of individual receptors that
have to be integrated within the signaling pathway to allow
the cell to decide whether to proliferate or not. Our data
allows us to estimate to what extent the calcium signal is al-
ready integrated. The pattern of elevation of the intracellu-
lar calcium elicited by different peptides is not only quanti-
tatively different, but qualitatively as well. Antagonism is
more effective at a higher dilution of the agonist peptides
into the antagonist. A blocking anti-CD4 antibody reduces
the calcium signal. These three observations suggest that a
T cell has counted and qualified the different signals through
TCR and CD4 before the elevation of the intracellular cal-
cium concentration. In the process of signal integration, the
calcium signal thus seems to be much closer to the final
proliferation decision than to the events elicited directly by
the single engaged receptors.
Altered Ligands. With respect to TCR antagonist ligands,
recently Sloan-Lancaster et al. (47) have shown that several
antagonist ligands can induce weak calcium fluxes and sug-
gest that this might be part of an antagonist signal. Our own
data shows that whereas two different antagonist stimuli (102G
alone or 102S 1 aCD4 antibody) generate detectable, but
reduced calcium responses, one (99R) does not. This indi-
cates that the mobilization of intracellular calcium is not nec-
essary for antagonist peptide–MHC ligands to block a re-
sponse. Thus, their primary effect may lie upstream in the
T cell signaling process. Similarly, Windhagen et al. (26)
have described an antagonistic peptide that does not induce
a calcium signal. Also consistent with a more TCR proxi-
mal effect of antagonism are the data of Sloan-Lancaster et
al. (32) and Madrenas et al. (31) showing alterations in
CD3-g phosphorylation and subsequent ZAP-70 associa-
tion as a consequence of antagonist ligand engagement.
Figure 6. Antagonism. (A) Percentages of each signal type (as ex-
plained in Fig. 3) for dilution of MCC into different peptides as given be-
low the bars. 99T102A indicates the peptide 93E99T102A. 102S/CD4
indicates 102S in the presence of 100 ng/ml anti-CD4 antibody GK1.5.
The left five bars show, as indicated on the top, the data for the 1:1,000
dilutions of MCC, resulting in 25 nM MCC concentration. The right
five bars show the data for the 1:10,000 dilutions, resulting in 2.5nM
MCC concentration. (B) Cumulative representation of percent of cells
activated (irrespective of the type of signal) during a specific onset time
interval for the 1:1,000 dilutions of MCC into antagonist peptides, as in-
dicated in the header. Time axis as in Fig. 4 B.1822 Kinetics and Extent of T Cell Activation
Kinetics of the Onset Delay: Evidence for a Rate-limiting Step
in Triggering a T Cell Calcium Signal with a Half-life of a Few
Minutes. In this report, we determined the time between
initial T cell–APC contact and onset of the calcium re-
sponse. Comparing all activation conditions, we find that a
minimal delay of 45 s is seen for the MCC peptide at high
as well as low concentrations. Therefore, this initial delay
must reflect events that are independent of the stimulus
strength. Likely factors in this time frame are the time re-
quired for the establishment of cell–cell adhesion and for
the transmission of intracellular signals from the membrane
to the calcium stores.
Weak stimuli, such as partial agonist or antagonist pep-
tides, result in an additional onset delay of up to 10 min.
Recent studies have demonstrated that, in most cases,
partial agonists and antagonists dissociate more rapidly from
a given TCR than agonist ligands (28–30). Therefore, most
altered peptide ligands should reach steady-state with re-
spect to TCR binding more rapidly than agonist ligands.
Furthermore, one characteristic of the onset delay is that large
changes in the peptide dose result in only small changes in
the activation time (Fig. 4). For example, going from
250 nM to 25 nM of the peptide 102S causes only a 40%
increase in the onset time. If the formation of individual
TCR–peptide–MHC pairs was the rate-limiting step in the
induction of the calcium signal there would be, for con-
centrations of free MHC–peptide smaller than the concen-
tration of free TCR, a linear increase in the onset time as
the peptide concentration decreases. If the formation of
TCR–peptide–MHC oligomers was critical there would be
an even more dramatic increase in the onset time as a func-
tion of peptide concentration. Even more sophisticated
models in which TCR–peptide–MHC mono- or oligo-
mers need to interact for some minimal time in order for
signaling to occur do not fit the observed peptide depen-
dency of the onset delay (Kantor, R., C. Wülfing, and
M.M. Davis, unpublished results). Thus, the increased on-
set time observed for weak stimuli does not appear to de-
pend on some threshold level of TCR ligation or oligo-
merization. This is not to say that oligomerization does not
occur or that the half-life of the TCR–peptide–MHC
complex is not important, as other studies have shown that
it is (30, 33), but that these factors may not be rate-limiting
at the cellular level.
Instead, we suggest that the rate-limiting factor in this
delay reflects intracellular reactions leading to the accumu-
lation of signaling molecules. These reactions could involve
a continuous competition between phosphorylation and
Figure 7. Model of onset effect. The figure represents the accumula-
tion of the critical signaling component B that has to reach the trigger
concentration Btr to induce the calcium response. The mathematics of the
model is given in the Materials and Methods section. Graphs for different
values of the rate constants k1 and k21 are shown. k21 is set to 1 in all
graphs to represent a constant removal of B. The postulated trigger to be
reached for the induction of the calcium signal is the production of the
half-maximal amount of B. The rate of formation of B, k1, is varied in the
three panels. It varies between 7.5 and 15 for A, as to represent the fast
formation of the signaling intermediate under different concentrations of
the agonist peptide, MCC. No onset delay is seen. k1 is set to values be-
tween 2 and 7.5 in B to represent the postulated formation of the signal-
ing intermediate by different concentrations of the partial agonist, 102S.
The formation of B is not much faster than its removal. This results in a
strong onset effect. In C, the rate formation of B is 0.9. Because the rate
of formation is smaller than the rate of removal, the trigger concentration
is never reached on average, as to represent the antagonist peptide, 102G.1823 Wülfing et al.
dephosphorylation, or between production or breakdown
of other parts of the signaling machinery. We hypothesize
that T cell activation shifts the balance of this equilibrium
towards the accumulation of signaling molecules. A simple
kinetic model based on a reaction scheme of this type
agrees well with the onset delay that we observe (Fig. 7).
The crucial feature of this scheme is that the turnover of
the rate-limiting signaling intermediate is determined by an
activation strength-dependent first-order forward and an
activation strength independent first-order reverse reaction:
The concentration over time of this signaling intermedi-
ate B is given by B(t) 5 A0 3 (1 1 k21 / k1)21 3 (1 2 e(k1 1
k21)t) (see Materials and Methods for details).
The half-life of these reactions can be derived from our
kinetic data. Under the very weak activation conditions of
the antagonist 102G most calcium responses occur between
8–12 min. Because only a small percentage of the cells re-
spond, the reaction leading to signaling must be nearly com-
plete (i.e., at the new steady-state) before any responses oc-
cur. This is depicted in Fig. 7 C. Because the time to reach
95% of a new steady-state level of signaling intermediates is
four times the half-time, 2 min is a good approximation for
A
k1
k1 –
B
the half-time of the reaction towards the steady-state. At
the same time, this is the lower limit for the half-times of
the individual forward and reverse reactions of this steady-
state. The half-times of this stimulus-independent reverse
reaction and this forward reaction for 102G are a few min-
utes under the additional assumption that to trigger the cal-
cium response the accumulation of the signaling intermedi-
ate has to be substantial but not complete (Fig. 7 C). The
half-times of the forward reaction for stronger activation
conditions would be shorter. As these measurements were
done at 258C, one must also allow for a two to four times
acceleration in this value at 378C. In a broader biological
picture, we thus suggest that the accumulation of a signal-
ing intermediate triggers the calcium signal. This interme-
diate is continuously degraded with a half-time of a few
minutes. Therefore, every T cell stimulus that results in cal-
cium signaling has to produce this intermediate with a half-
time of less than a few minutes.
Other early processes in T cell activation occur within a
similar time frame. One example is z chain phosphoryla-
tion (31, 32), which reaches steady-state within a few min-
utes for agonist signaling and within 2–10 min for antago-
nist signaling (32). Such a reaction could produce the
postulated critical signaling intermediate.
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